Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516653 | SCV000612537 | pathogenic | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | This variant segregates with hemiplegic migraine with progressive cerebellar ataxia in at least one family and has also been seen in at least one de novo case. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). Computational tools predict that this variant is damaging. |
Ce |
RCV000516653 | SCV001248620 | pathogenic | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000516653 | SCV001447587 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000516653 | SCV002552987 | likely pathogenic | not provided | 2022-01-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27435762, 15032980, 29482223, 33790770) |
Juno Genomics, |
RCV004795386 | SCV005415799 | pathogenic | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | criteria provided, single submitter | clinical testing | PM2_Supporting+PP2+PS4+PM6+PP1_Moderate+PP3_Strong+PP4 | |
OMIM | RCV000009039 | SCV000029256 | pathogenic | Migraine, familial hemiplegic, 1 | 2008-11-01 | no assertion criteria provided | literature only | |
Uni |
RCV000009039 | SCV000090852 | not provided | Migraine, familial hemiplegic, 1 | no assertion provided | not provided | ||
Solve- |
RCV004766990 | SCV005091511 | likely pathogenic | Developmental and epileptic encephalopathy, 42 | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |